Health Bulletin 12/January/2022

"On a lighter side, you on one hand are saying you are competitive. But when asked to appear in NEET, you are saying we are not," the bench, also comprising Justice Jyoti Singh, told the counsel for the petitioner.

For more information check out the full story on the link below:

AYUSH doctors performing surgeries, validity of NEET for AYUSH courses: HC to hear matter together in March

 MCC NEET PG Counselling Scheme Modified, Check Out 5 Major Changes

With the release of NEET PG Counselling 2021, the Medical Counselling Committee (MCC) has notified about the 5 major changes in the counselling scheme for this academic year's PG medical admission process.

For more information check out the full story on the link below:

MCC NEET PG Counselling Scheme Modified, Check out 5 major changes

Covaxin Booster Dose Safe, Says Bharat Biotech 

Covaxin manufacturer Bharat Biotech on Saturday said that the booster dose trials have shown "promising results" of long-term safety with "no serious adverse events"

The Hyderabad-based company announced the results on the safety and immunogenicity of COVAXIN (BBV152),a whole-virion inactivated COVID-19 vaccine as a booster dose.

"Covaxin trial demonstrated long-term safety with no serious adverse events. 90 per cent of recipients had a detectable neutralizing antibody response against the wild-type strain (six months after the second dose)." Bharat Biotech said in an official statement.

For more information check out the full story on the link below:

Covaxin Booster Dose Safe, Says Bharat Biotech